Trademark applications and grants for Primus Pharmaceuticals, Inc.. Primus Pharmaceuticals, Inc. has 38 trademark applications. The latest application filed is for "KINSIMOVE"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | 7373 N. Scottsdale Road, Suite B-200 Scottsdale, ARIZONA UNITED STATES 85253 |
Patent Application | Date |
---|---|
METHODS OF TREATING AUTOIMMUNE MICROVASCULAR DISORDERS 20220168267 - 17/670609 Levy; Robert M. | 2022-06-02 |
TOPICAL FORMULATIONS COMPRISING A STEROID 20210386758 - 17/143648 UBAIDULLA; Udhumansha ;   et al. | 2021-12-16 |
REDUCED DOSE METAXALONE FORMULATIONS 20200405693 - 16/524952 Gande; Mukteeshwar ;   et al. | 2020-12-31 |
METHODS OF TREATING AUTOIMMUNE MICROVASULAR DISORDERS 20200147031 - 16/632032 Levy; Robert M | 2020-05-14 |
COMBINATIONS OF GENISTEIN AND BISPHOSPHONATES 20190380999 - 16/435876 Yamaguchi; Masayoshi | 2019-12-19 |
NCAGE Code | 61UD5 | PRIMUS PHARMACEUTICALS, INC. |
CAGE Code | 61UD5 | PRIMUS PHARMACEUTICALS, INC. |
SEC | 0000819400 | PRIMUS PHARMACEUTICALS INC of GEORGIA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.